Skip to content

Why Is Clover Health And Wellness (CLOV) Stock Up Today? Director Chelsea Clinton bought 100,000 shares of CLOV stockĀ 

Right now, shareholders of Clover Health and wellness (NASDAQ: CLOV) are smiling ear to ear. Although CLOV stock stays down more than 25% year-to-date (YTD), shares of the business are up over 20% today.

Why precisely is Clover Health trading greater right now?

Over the weekend break, it was reported that Clover supervisor Chelsea Clinton had lately purchased shares of CLOV stock. The transaction, which occurred on March 3, saw Clinton purchase 100,000 shares for an average price of $2.52 per share. In overall, Clinton’s recent deal totaled up to $252,530, according to a Type 4 submitted to the united state Securities and also Exchange Compensation (SEC).

Why Is CLOV Stock Up Today?
Right now, CLOV stock is up in reaction to Clinton’s acquisition, which capitalists are considering as a positive signal. Often times, supervisor trading activity similar to this is necessary to track since insiders typically have a better view of a company’s lasting growth potential than retail capitalists.

So, with that said in mind, are other insiders of Clover favorable on the firm? In the past 12 months, experts have bought 2.2 million shares and offered 22.9 million shares. That’s a web of 20.6 million shares sold. This mass expert selling appears to associate with CLOV stock’s decline of greater than 60% over the past one year.

Still, with Clinton’s recent purchase, investors are questioning that else is betting big on Clover Wellness. Let’s jump right in.

That Else Is Betting Big on Clover Health?
As of the fourth quarter, 160 institutional capitalists very own shares of CLOV stock. That marks a quarter-0ver-quarter (QOQ) boost of 8.8%. During the duration, the overall quantity of shares held by institutional financiers also boosted from 105.7 million to 129.8 million, up almost 23% QOQ. Allow’s have a look on top five institutional investors.

Vanguard has 25.9 million shares or 7.65% ownership. The company bought 8.8 million shares during Q4.
Greenoaks Capital Allies owns 24.8 million shares or 7.34% possession. The company offered 24.8 million shares throughout Q4.
Baillie Gifford has 7.8 million shares or 2.3% possession. The firm purchased 2.6 million shares throughout Q4.
Two Sigma Investments has 6.6 million shares or 1.95% ownership. The company bought all 6.6 million shares during Q4.
PNC Financial Services (NYSE: PNC) possesses 6.4 million shares or 1.88% possession. The firm offered 249,850 shares throughout Q4.
Out of the leading 5 investors, 3 funds minimized their settings as well as 2 funds raised their settings. Greenoaks Funding Allies had the most significant purchase, as the fund marketed concerning 50% of its existing setting during Q4. 2 Sigma’s 6.6 million share acquisition was likewise remarkable, as the purchase put it among the leading five investors.